Impax and J&J settle Concerta patent lawsuits

Impax and J&J settle Concerta patent lawsuits

    Impax says its generic version of Concerta will go on sale in July 2013 in settlement with J&J

    NEW YORK (AP) -- Impax Laboratories Inc. said Friday its generic version of the attention deficit hyperactivity drug Concerta should go on sale in July after the company settled lawsuits with drugmaker Johnson & Johnson.

    Impax and Teva Pharmaceutical Industries Ltd. received a license to start selling their generic on July 14, 2013. Impax said U.S. sales of Concerta totaled $1.2 billion over the 12-month period ending in July. That includes the brand-name version and an authorized generic made by Watson Pharmaceuticals Inc.

Click here to read more

(Associated Press)